spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Odyssey 

 HSMN NewsFeed - 9 Nov 2022
Odyssey Therapeutics Expands Management Team with Key Appointments in Research Development and Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 25 Aug 2017
Regeneron and Sanofi to Present New Analyses from Praluent(R) (alirocumab) Injection Trials at the ESC Congress 2017
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Apr 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 6 Jan 2017
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals
 HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Sep 2015
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Jul 2015
Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan
Devices Cardiology
 HSMN NewsFeed - 27 Mar 2015
Florida Hospital First in U.S. to Use Stereotaxis Vdrive(R) Duo(TM) System to Control Multiple Diagnostic Devices
Devices Cardiology
 HSMN NewsFeed - 11 Mar 2015
Mylan Launches Generic Antabuse(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jan 2015
Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2015
Stereotaxis Receives FDA Clearance of Vdrive(R) With V-CAS(TM) System Along With Regulatory Approval of Odyssey(R) System in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Sep 2014
Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System
Devices FDA
 HSMN NewsFeed - 1 Apr 2014
Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) with V-Loop(TM) System
Devices Cardiology Interventional FDA
 HSMN NewsFeed - 14 Feb 2014
Stereotaxis Appoints William C. Mills III to Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 21 Jan 2014
Affymetrix Receives FDA Clearance of First-of-its-kind Postnatal Test for Developmental Delays and Intellectual Disabilities in Children
Diagnostics FDA
 HSMN NewsFeed - 7 Jan 2014
Stereotaxis Completes Clinical Trial of Vdrive(TM) With V-Loop(TM) System
Devices Cardiology
 HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 23 Oct 2013
Stereotaxis Niobe(R) System Receives Highest Reimbursement Classification in Japan
Devices Cardiology Reimbursement
 HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Mar 2013
Stereotaxis Receives Regulatory Approval of Niobe(R) Technology in Japan; Begins Commercialization Efforts
Devices Cardiology Regulatory
 HSMN NewsFeed - 30 May 2012
Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 5 May 2011
Stereotaxis and Biosense Webster Announce New Strategic Collaboration
Devices Cardiology Distribution
 HSMN NewsFeed - 23 Feb 2011
Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
Devices Interventional
 HSMN NewsFeed - 22 Feb 2011
Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 11 Jan 2011
Stereotaxis Announces CE Mark and First Human Case for Vdrive
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Nov 2010
DICOM Grid Secures $7.5 Million in Funding Led by Canaan Partners
Devices Radiology Venture Capital
 HSMN NewsFeed - 1 Nov 2010
Vascular Pathways Inc. Completes Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Edwards Lifesciences Launches Magna Mitral Ease Valve
Devices Cardiology
 HSMN NewsFeed - 8 Sep 2010
Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
Devices Cardiology
 HSMN NewsFeed - 14 Jul 2010
BARRX Medical, Inc. Completes $15 Million Growth Financing
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 17 Feb 2010
Stereotaxis Procedure Prominently Featured on BBC Documentary 'From the Heart'
Devices Cardiology
 HSMN NewsFeed - 8 Feb 2010
Stereotaxis Installs First System in Taiwan
Devices Cardiology
 HSMN NewsFeed - 25 Jan 2010
Edwards Lifesciences Initiates Clinical Study of Minimally Invasive Aortic Valve Surgery System
Devices Cardiology Surgery
 HSMN NewsFeed - 4 Aug 2009
New Collagen Meniscus Implant Opens New Vista for Knee Repair
Devices Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 23 Oct 2008
Stereotaxis Announces Commercialization of Odyssey Cinema(TM)
Devices Interventional
 HSMN NewsFeed - 16 Oct 2008
Predictive Biosciences Closes $21.75 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 7 Oct 2008
Odyssey Thera Announces New Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jul 2008
Vertos Medical Inc. Completes Series C Financing
Devices Neurosurgery Orthopaedic Venture Capital
 HSMN NewsFeed - 7 Apr 2008
Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
Devices Personnel
 HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jan 2008
Wright Medical Group, Inc. Launches BIOFOAM(TM) Cancellous Titanium Tibial Base for Total Knee Replacement
Devices Orthopaedic
 HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2007
OpGen Announces $23.6 Million Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 22 Aug 2007
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 May 2007
Stereotaxis Introduces Odyssey(TM), the First Ever Fully Integrated and Networked Single Screen Solution for the Interventional Electrophysiology Lab
Devices Cardiology
 HSMN NewsFeed - 3 Nov 2006
IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2006
Wright Medical Group, Inc. Introduces Enhanced ODYSSEY(TM) ``Distal Cut First'' Instrumentation for Less Invasive Knee Procedures
Devices Orthopaedic
 HSMN NewsFeed - 1 Feb 2006
Guidant Acquisition Changes VC Investment Landscape for Medical Devices
Devices Venture Capital
Return to NewsFeed  

 Additional items found! 19

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 19 additional stories matching:
Odyssey
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.